Why Albemarle’s latest earnings matter for investors

Albemarle (ALB) reported second quarter 2026 earnings on August 5, with higher sales and net income than a year earlier, alongside full year guidance and an update on lithium volumes.

Since the earnings release on 5 August, Albemarle’s recent 7 day share price return of 7.07% contrasts with a 90 day share price decline of 35.62% and a 1 year total shareholder return of 68.13%, which signals recovering momentum after a weak few months.

If Albemarle’s earnings update has you reassessing the wider materials and energy transition space, this may be a good moment to scan 28 best rare earth metal stocks.

Albemarle’s share price has fallen sharply over 90 days yet still trades well below both analyst targets and some intrinsic value estimates. After this earnings rebound, where does fair value really sit within that wide gap?

Most Popular Narrative: 30.9% Undervalued

Against Albemarle’s last close of $129.36, the most followed narrative points to a fair value of $187.16, which is described as a lower but still supportive view of the stock’s long term potential.

Albemarle’s disciplined capital spending (60% CapEx reduction YoY and ongoing prioritization of highest-return projects) and improved cash conversion is enabling it to generate positive free cash flow, strengthen its balance sheet, and provide greater financial flexibility for future growth, which can bolster earnings as demand recovers and pricing normalizes.

Want to see why a company with modest revenue assumptions ends up with such a strong earnings profile in this narrative? The real swing factor is how margins and the chosen profit multiple interact over time.

The narrative uses a 7.41% discount rate and a detailed path for Albemarle’s revenue, margins and future earnings to arrive at a fair value of $187.16. It then asks whether that long term earnings profile justifies a future profit multiple that sits below the current industry average yet still supports a much higher valuation than today’s share price.

Result: Fair Value of $187.16 (UNDERVALUED)

However, this Albemarle narrative still leans heavily on assumptions about tighter lithium markets and higher future margins. These assumptions could be challenged if oversupply and weak pricing persist.

Another view on Albemarle’s valuation

The narrative around Albemarle leans heavily on earnings forecasts and future profit margins, yet the current P/S of 2.6x paints a different picture. It sits above the US Chemicals industry at 1.2x and above the fair ratio of 1.9x, which points to valuation risk if sentiment cools.

Investors comparing these signals may want to stress test their own assumptions about future margins, lithium pricing and cash generation before relying on any single approach, and then weigh how comfortable they are paying more than both peers and the fair ratio for that future earnings profile. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment on Albemarle finely balanced between opportunity and risk, this is a moment to check the data yourself and move quickly while the latest information is still fresh. Start by weighing the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Albemarle?

Do not stop with Albemarle. Use the Simply Wall St screener to spot other opportunities that fit your style before the market moves on without you.

• Target higher quality at sensible prices by scanning 49 high quality undervalued stocks that combine stronger fundamentals with more appealing valuations.
• Strengthen portfolio resilience by focusing on companies in the 85 resilient stocks with low risk scores that carry lower overall risk scores.
• Spot potential early movers before they gain wider attention with the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.